Press Releases



 
Press Releases
  Date Title View
Sep 6, 2006
REDWOOD CITY, Calif., Sept 06, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today provided initial comment on the U.S. Food and Drug Administration's (FDA) draft guidance on "In Vitro Diagnostic Multivariate Index Assays." "This draft guidance represents the first public discussion surrounding the A...
PDF
Sep 1, 2006
REDWOOD CITY, Calif., Sept 01, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Ph.D., Genomic Health's Chairman and Chief Executive Officer, will present at the Thomas Weisel Partners Healthcare Conference in Boston, MA on Wednesday, September 6 at 3:50 PM Eastern Time. ...
PDF
Aug 1, 2006
REDWOOD CITY, Calif., Aug 01, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results for the second quarter and six months ended June 30, 2006. Total revenue was $8.4 million in the second quarter of 2006, compared to $1.2 million in the second quarter of 2005. Oncotype DX pro...
PDF
Jul 25, 2006
REDWOOD CITY, Calif., July 25, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, August 1, 2006 at 4:30 p.m. Eastern Time to discuss its second quarter financial results. The call and webcast will follow the release of the s...
PDF
Jun 8, 2006
REDWOOD CITY, Calif., June 8, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, Genomic Health's President and Chief Operating Officer, will present at the 2006 Pacific Growth Equities Life Sciences Growth Conference in San Francisco, CA on Tuesday, June 13 at 4:00 p.m. Pa...
PDF
Jun 6, 2006
ATLANTA, June 6, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive results from two studies that further demonstrate the value and clinical utility of quantifying gene expression to individualize treatment planning for early-stage breast cancer patients. These studies, along with fi...
PDF
Jun 4, 2006
ATLANTA, June 4, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- The Pittsburgh-based National Surgical Adjuvant Breast and Bowel Project (NSABP) and Genomic Health, Inc. (Nasdaq: GHDX) today announced positive results of a new study that identified genes associated with prognosis in patients with stage II and III colon cancer treated with ...
PDF
Jun 2, 2006
REDWOOD CITY, Calif., June 2, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced three poster presentations scheduled for the Annual Meeting of the American Society of Clinical Oncology taking place in Atlanta, GA, from June 2 - 6, 2006. Following are details for each embargoed session: S...
PDF
May 31, 2006
REDWOOD CITY, Calif., May 31, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the journal Breast Cancer Research published results from a large clinical study conducted by Kaiser Permanente confirming that Oncotype DX, the company's breast cancer test service, also helps predict the l...
PDF
May 23, 2006
REDWOOD CITY, Calif. – May 23, 2006 – Genomic Health, Inc. (Nasdaq: GHDX) today announced that the Journal of Clinical Oncology (JCO) published results of a large-scale trial conducted with the National Surgical Adjuvant Breast and Bowel Project (NSABP) confirming the Oncotype DX 21-gene panel, which quantifies the risk of breast cancer r...
PDF
FirstPrevious
...
38
NextLast